top of page
Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
Funds will help support the development of COYA 302 for the treatment of Frontotemporal Dementia (FTD) COYA 302’s combination therapeutic...
NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX...
Hopewell Therapeutics to Present Data Highlighting Novel Tissue Targeting Lipid Nanoparticles at the American Society of Gene and Cell Therapy 27th Annual Meeting
WOBURN, Mass., May 7, 2024 /PRNewswire/ -- Hopewell Therapeutics, a biotechnology company focused on discovering, synthesizing, and...
Press
bottom of page